Home › Funds › MPM BioImpact LLC › CRBP

MPM BioImpact LLC position in CRBP

CORBUS PHARMACEUTICALS HLDGS · Health Care

MPM BioImpact LLC reported holding 1,667,272 shares of CRBP (CORBUS PHARMACEUTICALS HLDGS) in its Q3 2026 13F filing — a position valued at US$11.4M, representing 0.88% of its reported portfolio and ranking #34 among its reported holdings. MPM BioImpact LLC first reported this position in Q3 2026.

Latest position (Q3 2026)1.67M sh
Reported value held$11.37M
Portfolio Weight0.88%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How MPM BioImpact LLC's CRBP position evolved

MPM BioImpact LLC first disclosed a stake in CRBP in Q3 2026 at 1,667,272 shares (US$11.4M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 1.67M $11.37M New

About CRBP and 13F data

CRBP (CORBUS PHARMACEUTICALS HLDGS) is a Health Care company. 25 other funds we track also report a position in CRBP — the largest reported positions include Cormorant Asset Management, LP (US$16.0M), Jones Hill Capital LP (US$6.0M), DIADEMA PARTNERS LP (US$5.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRBP

All CRBP fund holders →

FAQ

How long has MPM BioImpact LLC held CRBP?

MPM BioImpact LLC has disclosed CRBP holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is MPM BioImpact LLC's current position in CRBP?

As of Q3 2026, MPM BioImpact LLC holds 1.67M shares of CRBP (CORBUS PHARMACEUTICALS HLDGS), valued at $11.37M, representing 0.88% of its reported portfolio and ranking #34.

Has MPM BioImpact LLC been buying or selling CRBP?

In the latest 13F filing (Q3 2026), MPM BioImpact LLC newly opened its position in CRBP.

Which other funds hold CRBP?

Other major institutional holders of CRBP include Cormorant Asset Management, LP, Jones Hill Capital LP, DIADEMA PARTNERS LP, among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.